Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today plans to invest more than $700 million ...

Genentech plans to invest $700 million in a new facility in Holly Springs, North Carolina, creating 420 jobs and joining the ...

HOLLY SPRINGS, N.C. -- Genentech, a leading biotechnology company based in San Francisco, is set to build a $700 million ...

Genentech, considered one of the biotech industry’s founding companies, plans to build a $700 million, 700,000-square-foot ...

The commitment is part of Roche’s recently announced $50 billion investment in the U.S., but a company spokesperson said that ...

Genentech, a member of the Roche Group, will create 400 jobs with a new biotechnology facility in Holly Springs, Wake County, ...

Genentech unit plans to invest more than $700M in a new drug manufacturing facility in Holly Springs, North Carolina. The ...

The project could eventually add more than 400 manufacturing jobs and over 1,500 construction jobs during site development.

North Carolina's life sciences sector continues to attract major investments with the potential for thousands of jobs.

Genentech, one of the world's premiere biotechnology companies headquartered in South San Francisco, California, announced it ...

The committee awarded a grant to Genentech, a Roche subsidiary, to open a 420-worker, drug-manufacturing plant in the ...

Roche Group said on Monday that it plans to invest more than $700 million in a new drug manufacturing facility in North ...